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strains
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nicolas Barnich7 & Margarita Martinez-Medina1 ✉
Adherent-invasive Escherichia coli (AIEC) have been extensively implicated in Crohn’s disease 
pathogenesis. Currently, AIEC is identified phenotypically, since no molecular marker specific for 
AIEC exists. An algorithm based on single nucleotide polymorphisms was previously presented as a 
potential molecular tool to classify AIEC/non-AIEC, with 84% accuracy on a collection of 50 strains 
isolated in Girona (Spain). Herein, our aim was to determine the accuracy of the tool using AIEC/non-
AIEC isolates from different geographical origins and extraintestinal pathogenic E. coli (ExPEC) strains. 
The accuracy of the tool was significantly reduced (61%) when external AIEC/non-AIEC strains from 
France, Chile, Mallorca (Spain) and Australia (82 AIEC, 57 non-AIEC and 45 ExPEC strains in total) were 
included. However, the inclusion of only the ExPEC strains showed that the tool was fairly accurate at 
differentiating these two close pathotypes (84.6% sensitivity; 79% accuracy). Moreover, the accuracy 
was still high (81%) for those AIEC/non-AIEC strains isolated from Girona and Mallorca (N = 63); two 
collections obtained from independent studies but geographically close. Our findings indicate that the 
presented tool is not universal since it would be only applicable for strains from similar geographic origin 
and demonstrates the need to include strains from different origins to validate such tools.
The involvement of the adherent-invasive Escherichia coli (AIEC) pathotype in Crohn’s disease (CD) pathogen-
esis has been extensively supported, as many researchers have reported higher AIEC prevalence in CD patients 
than controls1–9, and mechanisms of pathogenicity have been linked with CD pathophysiology10–17. The ability 
to adhere to and invade intestinal epithelial cells, as well as, to survive and replicate inside macrophages are key 
characteristics of AIEC strains2. No gene or sequence exclusive to the AIEC pathotype has been identified, and 
AIEC identification currently remains challenging; the only way to identify an AIEC strain is by assessing bacte-
rial infection in cell culture assays which are non-standardised and highly time-consuming2.
AIEC strains isolated to date are clonally diverse and belong to distinct serotypes. Although AIEC primar-
ily fall into the B2 phylogroup, AIEC strains belonging to the A, B1, and D phylogroups have also been iso-
lated1,3,4,6,9,18–23. In terms of virulence genes, AIEC resemble extraintestinal pathogenic E. coli (ExPEC), which 
are mostly non-invasive and the majority of them do not behave like AIEC3,24–26, with the exception of some 
isolates26,27.
Up to now, six genetic elements (pduC, lpfA, lpfA + gipA, chuA, 29 point mutations and 3 genomic regions) 
have been suggested as putative AIEC molecular markers6,21,23,28,29, however they either present low sensitiv-
ity or have been studied in a small number of strains. In a previous study conducted in our research group30, 
we designed a classification algorithm based on the identification of the nucleotides present in three Single 
Nucleotide Polymorphisms (SNPs). This algorithm displayed 82.1% specificity, 86.4% sensitivity and 84.0% 
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accuracy within our Spanish strain collection. Given the high genotypic variability of AIEC, our aim was to 
validate the tool previously presented in AIEC/non-AIEC strains from distant geographical origins and ExPEC 
strains in order to assess the usefulness of these SNPs as molecular signatures for AIEC screening in external 
collections.
Results
Confirmation of the validity of the algorithm30 in additional geographically distant AIEC/non-AIEC and ExPEC 
strains was performed.
When all AIEC/non-AIEC strains from Girona, Mallorca, France, Chile and Australia, as well as ExPEC 
strains were analysed, 73/98 of the non-AIEC strains were correctly classified but only 39/86 of the AIEC strains 
were appropriately predicted, resulting in a high probability of obtaining false negatives (54.6%). Therefore, in 
comparison to the values obtained within our strain collection (82.1% specificity, 86.4% sensitivity and 84.0% 
accuracy), the global accuracy was significantly reduced (60.9%), with decreased specificity (74.5%) and espe-
cially lower sensitivity (45.4%) (Table 1, Fig. 1). In contrast to the previous study30, the SNPs that were found to be 
differentially distributed among our AIEC and non-AIEC strains (E3-E4_4.4 and E5-E6_3.16 = 3.22(2)) showed 
similar frequencies according to phenotype when all the strains were considered (Table 2). According to the 
algorithm30, strains displaying guanine (G) in SNP E3-E4_4.4 are classified as non-AIEC, and the same occurs for 
those that do not have the gene (−) where SNP E3-E4_4.4 is located and display a nucleotide other than G at SNP 
E5-E6_3.16 = 3.22(2). Indeed, most AIEC strains (54.6%) were incorrectly classified because they accomplished 
these conditions (Fig. 2). Other possible SNP combinations were considered for all the strains included in the 
study but none improved the precision of the algorithm.
Despite global accuracy of the algorithm being much lower when all strains were considered, the method was 
suitable for geographically close strain collections. Indeed, if only Spanish strains (Girona and Mallorca) (N = 63) 
were considered, the accuracy of the tool was maintained (80.9%) (Table 1). Specificity was also good (82.3%), 
meaning there was a low probability of false positives (17.7%) (Fig. 1). Therefore, strains from different laboratory 
collections, but of similar geographical origin, were suitable for screening by this method.
The inclusion of ExPEC strains (N = 45) revealed that the tool was also useful for distinguishing the ExPEC 
and AIEC pathotypes, since 84.6% of strains displaying the AIEC phenotype were correctly classified, with a 
global accuracy of 78.9% (Table 1, Fig. 1).
These results demonstrated that the classification algorithm presented has limited applicability for all E. coli 
strains assessed. However, this novel molecular tool showed promising results for Spanish AIEC and ExPEC 
strains.
Discussion
The identification of molecular tools or rapid tests to easily identify the AIEC pathotype would be of great interest 
to scientists studying the epidemiology of the pathotype, as well as clinicians hoping to detect which patients are 
colonised by AIEC to apply personalised treatments. Although several studies have been conducted with this aim 
in mind, there is still no molecular signature specific to AIEC6,21,23,28,29.
Observed
Predicted Predictive Values
Non-AIEC AIEC % Correct Accuracy
AIEC/non-AIEC Spain (Girona)30
Non-AIEC 23 5 82.1
84.0
AIEC# 3 19 86.4
AIEC/non-AIEC Spain (Mallorca)6
Non-AIEC 5 1 83.3
69.2
AIEC 4 3 57.1
AIEC/non-AIEC France
Non-AIEC 0 0 0
32.3
AIEC 23 11 32.3
AIEC/non-AIEC Chile6
Non-AIEC 3 0 100
33.3
AIEC 6 0 0
AIEC/non-AIEC Australia33
Non-AIEC 12 8 60.0
42.4
AIEC 11 2 15.4
ExPEC Spain and USA26,35,36
Non-AIEC 30 11 73.2
73.3
AIEC 1 3 75.0
AIEC/non-AIEC Spain (Girona) and 
ExPEC
Non-AIEC 53 16 76.8
78.9
AIEC 4 22 84.6
AIEC/non-AIEC Spain (Girona) and AIEC/
non-AIEC Spain (Mallorca)
Non-AIEC 28 6 82.3
80.9
AIEC 6 23 79.3
All strains*
Non-AIEC 73 25 74.5
60.9
AIEC 47 39 45.4
Table 1. Summary table of the accuracy of the tool in each strain collection analysed. #Include LF82 as AIEC 
reference strain. *Include AIEC/non-AIEC strains from Girona, Mallorca, France, Chile and Australia, as well 
as, ExPEC strains from Spain and USA.
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In a previous study we performed comparative genomics of three AIEC/non-AIEC clone pairs and presented 
a classification algorithm that combines three SNPs, allowing for the classification of phylogenetically and phe-
notypically diverse E. coli isolates with a high accuracy rate in our strain collection30. Since the application of a 
molecular tool could assist in overcoming the problem of AIEC identification, we further tested the specificity 
and sensitivity of the tool in additional geographically distant and phylogenetically diverse AIEC strains, as well 
as ExPEC strains, which share genetic and phenotypic features3,24–26.
The tool was found to be accurate enough to distinguish between AIEC and ExPEC strains, since the sensitiv-
ity was 84.6% and the accuracy was 78.9%. In this case, we assessed both AIEC/non-AIEC from Girona (Spain) 
and ExPEC strains, the latter being mostly Spanish isolates. These results indicated that for a given geographic 
origin this algorithm could be applied to differentiate ExPEC from AIEC. So far, most of the studies looking 
for AIEC biomarkers have not included ExPEC strains in their analysis6,21,23,28. There is only one that focused 
Figure 1. Geographical distribution of the isolates assessed in four groups of analysis and the percentage of 
strains that are correctly (green) or incorrectly (red) predicted by the SNP algorithm in comparison with their 
previous phenotypic characterisation. (A) AIEC/non-AIEC strains from Girona (Spain)30, including LF82 as 
a reference strain; (B) ExPEC (Spain and USA)26,35,36 and AIEC/non-AIEC strains from Girona (Spain)30; (C) 
AIEC/non-AIEC strains from Girona (Spain)30 and AIEC/non-AIEC from France, Chile6, Spain (Mallorca)6, 
Australia33 and ExPEC-Spain26,36 and ExPEC-America35; (D) AIEC/non-AIEC strains from Girona30 and 
Mallorca6 (Spain).
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on synonymous and non-synonymous SNPs along the genome of four B2-AIEC strains that could differentiate 
them from other B2-non-AIEC and B2-ExPEC genomes available in databases. Although they found 29 SNPs 
that could separate AIEC from non-AIEC using a bioinformatics approach, but did not include the three SNPs 
in the presented algorithm, it did not find a signature sequence that distinguishes AIEC from ExPEC29. It is not 
possible to determine whether the high accuracy value we reported is due to similar geographic origin (40 from 
Spain and 5 USA) or not. Thus the inclusion of other ExPEC strains would be needed to validate the tool further. 
Unfortunately, the predicted values of the tool decreased considerably (60.9% of accuracy) when strains across 
several geographic regions were considered. AIEC isolates from France, Chile and Australia were poorly discrim-
inated with the SNP algorithm presented, resulting in significantly reduced sensitivity values (32.3, 0 and 15.4% 
respectively). Of note, this algorithm may be suitable for Spanish strains, because the accuracy was still high when 
two different collections of strains were studied (Girona and Mallorca) (80.9% accuracy). Taking into account 
that the variable gene content of E. coli is highly variable across different geographic regions31, this variation con-
tributes to the algorithm not being applicable across geographically diverse regions and it is subjected to possible 
variations in the accuracy presented in a particular country.
In conclusion, the molecular tool that we previously proposed30 is not universal since its accuracy was reduced 
to 60.9% once a larger strain collection from different geographic locations and pathotypes was screened. We 
suspect it might be a good discrimination tool for a particular geographic location, in this case Spain. However, 
this observation should be confirmed with the addition of other Spanish strain collections including AIEC, 
SNP Variant
Girona strain collection30
AIEC/non-AIEC from diferent 
geographic origins and ExPEC strains.
AIEC 
(N = 22)
Non-AIEC 
(N = 28) p-value
AIEC 
(N = 86)
Non-AIEC 
(N = 98) p-value
E3-E4_4.4
G 9.1 42.9
0.010
31.8 46.5
0.246
A 13.6 7.1 9.4 8.1
R 55.6 21.43 21.2 17.2
(−) 21.7 28.6 37.6 28.3
E5-E6_3.16 = 3.22(2)
G 31.8 3.6
0.012
24.7 14.9
0.237C 13.6 39.3 17.6 22.3
Others* 54.6 57.1 57.6 62.8
Table 2. Frequency of particular nucleotide variants in SNP E3-E4_4.4 and E5-E6_3.16 = 3.22(2) with respect 
to phenotype in two collections of AIEC/non-AIEC strains. Values are given in percentages with respect to the 
total number of AIEC or non-AIEC strains. *Others include those strains having T, S, K, Y or not having the 
gene where the SNP is encompassed.
Figure 2. Classification algorithm for AIEC identification. Assessed in our collection and external strain 
collections (France, Chile6, Spain (Mallorca)6, Australia33 and ExPEC-Spain26,36 and ExPEC-America35). 
Percentages represent the proportion of strains that are correctly predicted as AIEC or non-AIEC based on the 
result for each SNP combination. The number of total strains corresponding to each condition is indicated. (−): 
no amplification; other: a nucleotide different from guanine (G) or overlapping peaks.
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non-AIEC, and other E. coli intestinal and extraintestinal pathotypes. The study of new SNPs that could be useful 
to distinguish between AIEC/non-AIEC strains from different geographical origins might be time-consuming 
and unprofitable and should consider many aspects that make it even more complicated (for example, the 
moment of strain isolation and the patient’s treatment). Therefore, we believe that new approaches (e.g. transcrip-
tomics, metabolomics or epigenetics) should be applied to find a universal AIEC biomarker that could be used 
as a rapid standardised method for detecting AIEC from E. coli isolates, or maybe just E. coli isolates that have a 
strong colonizing ability. Nonetheless, there is a possibility that a no universal marker exists and then it would be 
interesting to look for a biomarker that englobes the majority of AIEC strains32. In any case, this work highlighted 
the importance of validating putative molecular markers in a diverse strain collection, in terms of geographic 
origin and pathotype, in order to assess whether or not it could be used universally.
Methods
The SNPs included in the algorithm (E3-E4_4.4, E5-E6_3.16 = 3.22(2) and E5-E6_3.12) were screened by PCR 
and Sanger sequencing. Primers and PCR conditions are indicated in Table 3. Apart from the strains assessed 
in the previous study (22 AIEC and 28 non-AIEC, which includes LF82 strain)30, this collection comprised 60 
AIEC and 29 non-AIEC strains mainly isolated from CD patients and controls from distinct geographical origin 
(Spain (Mallorca)6, Chile6, France and Australia33) (Table S1). Most of these strains were phenotypically charac-
terised in previous studies6,33. The adhesion and invasion indices of 25/33 Australian strains were measured in this 
study as previously described1,30,34 in order to classify them phenotypically as AIEC or non-AIEC. In addition, 45 
strains isolated from patients with extraintestinal diseases were also included; these were previously isolated from 
American patients with meningitis35, and Spanish patients with sepsis26 or urinary tract infection36 (Table S1). 
Phenotypic characterisation of these strains was performed by Martinez-Medina et al.26; in which four strains 
presented the AIEC-phenotype and were considered as such in the analysis and 41 did not (these were classified 
as non-AIEC).
Strains studied in this study were previously isolated under the approval of the Ethics Committee 183 of 
Clinical Investigation of the Hospital Josep Trueta of Girona on May 22 2006; Ethical 184 committee of Hospital 
Saint-Louis (CPP#2009/17); Institutional Review Board of Clínica Las 185 Condes, Faculty of Medicine, 
Universidad de Chile; Ethics Committee of the Northern 186 Metropolitan Health Service, Santiago, Chile; 
the Balearic Islands’ Ethical Committee, Spain; and 187 ACT Health Human Research Ethics Committee 
(ETH.5.07.464). Subjects gave written 188 informed consent in accordance with the Declaration of Helsinki.
The differences in the distribution of nucleotides present in each polymorphic site between phenotype were 
calculated using the Χ2 test. To establish the usefulness of the algorithm for AIEC identification, the specificity, 
sensitivity and accuracy values were measured as follows: Sensitivity (%)= (true positives/(true positives + false 
negatives)) × 100, Specificity (%)= (true negatives/(true negatives + false positives)) x 100; and, Accuracy (%)= 
((true positives + true negatives)/(total of cases)) × 100. A p-value ≤ 0.05 was considered statistically significant 
in all cases.
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